Mochida Pharmaceutical
Mochida Pharmaceutical Co Ltd is a Japanese pharmaceutical company developing, manufacturing, and marketing prescription drugs, medical devices, and skincare products. The company specializes in cardiovascular medicine, obstetrics, gynecology, analgesics, and immunology, producing flagship products such as Epadel (ethyl icosapentate) for hyperlipidemia and Lube, alongside medical ultrasound diagnostic equipment. Principal revenues derive from direct product sales of prescription pharmaceuticals and medical equipment to hospital networks, medical wholesalers, and retail pharmacies across Japan. Core end markets encompass cardiovascular specialty clinics, gynecology departments, hospital networks, and prescription patients in Japan. Mochida Pharmaceutical holds an established position in Japan's prescription pharmaceutical industry for cardiovascular and women's health therapeutics. The company is headquartered in Tokyo, Japan, and its common stock trades on the Prime Market of the Tokyo Stock Exchange.
3 of the funds FundTelligence covers report a position in Mochida Pharmaceutical.
- Legal name
- Mochida Pharmaceutical Co Ltd
- Sector
- Health Care
- Country
- Japan
- Funds holding it
- 3
Funds holding Mochida Pharmaceutical
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.0 % (partially disclosed portfolio, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.0 % (full portfolio disclosed, September 2026)